Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

3.51
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
0.50
Today|||52-Week Range
3.69
+550.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues992.0K127.0K2.5M351.0K
 
 
 
 
 
Depreciation And Amortization0.0023.0K0.000.00
 
 
 
Operating ExpensesGross Income----------
General Expenses6.6M9.5M10.3M9.2M
 
 
 
 
 
Research And Development4.4M7.7M8.0M6.9M
 
 
 
 
 
Total Operating Expenses6.6M9.6M10.3M9.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.6M-9.4M-7.8M-8.8M
 
 
 
 
 
Extraordinary Credit1.2M4.6M0.000.00
 
 
 
Extraordinary Charge0.000.00-484.0K-23.9M
 
 
 
Interest Expense On Debt551.0K561.0K551.0K530.0K
 
 
 
 
 
Other Expenses0.00-187.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.0M-5.6M-8.8M-33.3M
 
 
 
 
 
Income Taxes0.000.00-50.0K0.00
 
 
Net Income-5.0M-5.6M-8.8M-33.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS75.9M75.9M76.2M110.6M
 
 
 
 
 
Shares To Calculate EPS Diluted75.9M75.9M76.2M110.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.07-$0.12-$0.30
 
 
 
 
 
EPS Diluted-$0.07-$0.07-$0.12-$0.30